Connection

Inderjit Singh to Animals

This is a "connection" page, showing publications Inderjit Singh has written about Animals.
Connection Strength

3.050
  1. Vascular and immunopathological role of Asymmetric Dimethylarginine (ADMA) in Experimental Autoimmune Encephalomyelitis. Immunology. 2021 11; 164(3):602-616.
    View in: PubMed
    Score: 0.056
  2. Regulation of B cell functions by S-nitrosoglutathione in the EAE model. Redox Biol. 2021 09; 45:102053.
    View in: PubMed
    Score: 0.056
  3. Hypoxia-inducible factor-1 drives divergent immunomodulatory functions in the pathogenesis of autoimmune diseases. Immunology. 2021 09; 164(1):31-42.
    View in: PubMed
    Score: 0.055
  4. GSNOR and ALDH2 alleviate traumatic spinal cord injury. Brain Res. 2021 05 01; 1758:147335.
    View in: PubMed
    Score: 0.054
  5. Detoxification of Reactive Aldehydes by Alda-1 Treatment Ameliorates Experimental Autoimmune Encephalomyelitis in Mice. Neuroscience. 2021 03 15; 458:31-42.
    View in: PubMed
    Score: 0.054
  6. Targeting GSNOR for functional recovery in a middle-aged mouse model of stroke. Brain Res. 2020 08 15; 1741:146879.
    View in: PubMed
    Score: 0.051
  7. Peroxisomal footprint in the pathogenesis of nonalcoholic steatohepatitis. Ann Hepatol. 2020 Sep - Oct; 19(5):466-471.
    View in: PubMed
    Score: 0.050
  8. S-Nitrosoglutathione Mimics the Beneficial Activity of Endothelial Nitric Oxide Synthase-Derived Nitric Oxide in a Mouse Model of Stroke. J Stroke Cerebrovasc Dis. 2019 Dec; 28(12):104470.
    View in: PubMed
    Score: 0.050
  9. Regulation of IL-10 and IL-17 mediated experimental autoimmune encephalomyelitis by S-nitrosoglutathione. Immunobiology. 2018 10; 223(10):549-554.
    View in: PubMed
    Score: 0.045
  10. S-nitrosoglutathione reductase (GSNOR) inhibitor as an immune modulator in experimental autoimmune encephalomyelitis. Free Radic Biol Med. 2018 06; 121:57-68.
    View in: PubMed
    Score: 0.045
  11. Combination therapy of lovastatin and AMP-activated protein kinase activator improves mitochondrial and peroxisomal functions and clinical disease in experimental autoimmune encephalomyelitis model. Immunology. 2018 07; 154(3):434-451.
    View in: PubMed
    Score: 0.044
  12. Biochemical, cell biological, pathological, and therapeutic aspects of Krabbe's disease. J Neurosci Res. 2016 11; 94(11):990-1006.
    View in: PubMed
    Score: 0.040
  13. MicroRNA Profiling Identifies miR-196a as Differentially Expressed in Childhood Adrenoleukodystrophy and Adult Adrenomyeloneuropathy. Mol Neurobiol. 2017 03; 54(2):1392-1403.
    View in: PubMed
    Score: 0.038
  14. STAT3 Regulation By S-Nitrosylation: Implication In Cancer. Redox Biol. 2015 08; 5:416-417.
    View in: PubMed
    Score: 0.038
  15. AKP-11 - A Novel S1P1 Agonist with Favorable Safety Profile Attenuates Experimental Autoimmune Encephalomyelitis in Rat Model of Multiple Sclerosis. PLoS One. 2015; 10(10):e0141781.
    View in: PubMed
    Score: 0.038
  16. Blocking a vicious cycle nNOS/peroxynitrite/AMPK by S-nitrosoglutathione: implication for stroke therapy. BMC Neurosci. 2015 Jul 15; 16:42.
    View in: PubMed
    Score: 0.037
  17. S-Nitrosoglutathione-mediated STAT3 regulation in efficacy of radiotherapy and cisplatin therapy in head and neck squamous cell carcinoma. Redox Biol. 2015 Dec; 6:41-50.
    View in: PubMed
    Score: 0.037
  18. Oral administration of cytosolic PLA2 inhibitor arachidonyl trifluoromethyl ketone ameliorates cauda equina compression injury in rats. J Neuroinflammation. 2015 May 15; 12:94.
    View in: PubMed
    Score: 0.036
  19. ABCD1 deletion-induced mitochondrial dysfunction is corrected by SAHA: implication for adrenoleukodystrophy. J Neurochem. 2015 May; 133(3):380-96.
    View in: PubMed
    Score: 0.036
  20. S-Nitrosoglutathione protects the spinal bladder: novel therapeutic approach to post-spinal cord injury bladder remodeling. Neurourol Urodyn. 2015 Aug; 34(6):519-26.
    View in: PubMed
    Score: 0.034
  21. STAT3 regulation by S-nitrosylation: implication for inflammatory disease. Antioxid Redox Signal. 2014 Jun 01; 20(16):2514-27.
    View in: PubMed
    Score: 0.033
  22. PPARa activation induces N(e)-Lys-acetylation of rat liver peroxisomal multifunctional enzyme type 1. Lipids. 2014 Feb; 49(2):119-31.
    View in: PubMed
    Score: 0.033
  23. Histone deacetylase inhibitor upregulates peroxisomal fatty acid oxidation and inhibits apoptotic cell death in abcd1-deficient glial cells. PLoS One. 2013; 8(7):e70712.
    View in: PubMed
    Score: 0.032
  24. Modulation of Rho-Rock signaling pathway protects oligodendrocytes against cytokine toxicity via PPAR-a-dependent mechanism. Glia. 2013 Sep; 61(9):1500-1517.
    View in: PubMed
    Score: 0.032
  25. AMP-activated protein kinase signaling protects oligodendrocytes that restore central nervous system functions in an experimental autoimmune encephalomyelitis model. Am J Pathol. 2013 Aug; 183(2):526-41.
    View in: PubMed
    Score: 0.032
  26. Caffeic acid phenethyl ester induces adrenoleukodystrophy (Abcd2) gene in human X-ALD fibroblasts and inhibits the proinflammatory response in Abcd1/2 silenced mouse primary astrocytes. Biochim Biophys Acta. 2013 Apr; 1831(4):747-58.
    View in: PubMed
    Score: 0.031
  27. S-nitrosoglutathione induces ciliary neurotrophic factor expression in astrocytes, which has implications to protect the central nervous system under pathological conditions. J Biol Chem. 2013 Feb 08; 288(6):3831-43.
    View in: PubMed
    Score: 0.031
  28. Simvastatin ameliorates cauda equina compression injury in a rat model of lumbar spinal stenosis. J Neuroimmune Pharmacol. 2013 Mar; 8(1):274-86.
    View in: PubMed
    Score: 0.031
  29. The inhibitory effect of S-nitrosoglutathione on blood-brain barrier disruption and peroxynitrite formation in a rat model of experimental stroke. J Neurochem. 2012 Nov; 123 Suppl 2:86-97.
    View in: PubMed
    Score: 0.031
  30. Interference with RhoA-ROCK signaling mechanism in autoreactive CD4+ T cells enhances the bioavailability of 1,25-dihydroxyvitamin D3 in experimental autoimmune encephalomyelitis. Am J Pathol. 2012 Sep; 181(3):993-1006.
    View in: PubMed
    Score: 0.030
  31. N-acetylcysteine prevents preterm birth by attenuating the LPS-induced expression of contractile associated proteins in an animal model. J Matern Fetal Neonatal Med. 2012 Nov; 25(11):2395-400.
    View in: PubMed
    Score: 0.030
  32. Spinal cord injury induced arrest in estrous cycle of rats is ameliorated by S-nitrosoglutathione: novel therapeutic agent to treat amenorrhea. J Sex Med. 2012 Jan; 9(1):148-58.
    View in: PubMed
    Score: 0.028
  33. HDAC inhibitor SAHA normalizes the levels of VLCFAs in human skin fibroblasts from X-ALD patients and downregulates the expression of proinflammatory cytokines in Abcd1/2-silenced mouse astrocytes. J Lipid Res. 2011 Nov; 52(11):2056-69.
    View in: PubMed
    Score: 0.028
  34. S-nitrosoglutathione reduces oxidative injury and promotes mechanisms of neurorepair following traumatic brain injury in rats. J Neuroinflammation. 2011 Jul 06; 8:78.
    View in: PubMed
    Score: 0.028
  35. Synergistic activity of interleukin-17 and tumor necrosis factor-a enhances oxidative stress-mediated oligodendrocyte apoptosis. J Neurochem. 2011 Feb; 116(4):508-21.
    View in: PubMed
    Score: 0.027
  36. N-acetylcysteine attenuates the maternal and fetal proinflammatory response to intrauterine LPS injection in an animal model for preterm birth and brain injury. J Matern Fetal Neonatal Med. 2011 May; 24(5):732-40.
    View in: PubMed
    Score: 0.027
  37. Activation of PPAR-? and PTEN cascade participates in lovastatin-mediated accelerated differentiation of oligodendrocyte progenitor cells. Glia. 2010 Nov 01; 58(14):1669-85.
    View in: PubMed
    Score: 0.027
  38. Involvement of AMP-activated-protein-kinase (AMPK) in neuronal amyloidogenesis. Biochem Biophys Res Commun. 2010 Sep 03; 399(4):487-91.
    View in: PubMed
    Score: 0.026
  39. Very long-chain fatty acid accumulation causes lipotoxic response via 5-lipoxygenase in cerebral adrenoleukodystrophy. J Lipid Res. 2010 Jul; 51(7):1685-95.
    View in: PubMed
    Score: 0.025
  40. S-nitrosoglutathione a physiologic nitric oxide carrier attenuates experimental autoimmune encephalomyelitis. J Neuroimmune Pharmacol. 2010 Jun; 5(2):240-51.
    View in: PubMed
    Score: 0.025
  41. Administration of S-nitrosoglutathione after traumatic brain injury protects the neurovascular unit and reduces secondary injury in a rat model of controlled cortical impact. J Neuroinflammation. 2009 Nov 04; 6:32.
    View in: PubMed
    Score: 0.025
  42. Neuroprotective interventions: is it too late? J Child Neurol. 2009 Sep; 24(9):1212-9.
    View in: PubMed
    Score: 0.025
  43. Peroxisomal dysfunction in inflammatory childhood white matter disorders: an unexpected contributor to neuropathology. J Child Neurol. 2009 Sep; 24(9):1147-57.
    View in: PubMed
    Score: 0.024
  44. Attenuation of lipopolysaccharide-induced inflammatory response and phospholipids metabolism at the feto-maternal interface by N-acetyl cysteine. Pediatr Res. 2008 Oct; 64(4):334-9.
    View in: PubMed
    Score: 0.023
  45. Silencing of Abcd1 and Abcd2 genes sensitizes astrocytes for inflammation: implication for X-adrenoleukodystrophy. J Lipid Res. 2009 Jan; 50(1):135-47.
    View in: PubMed
    Score: 0.023
  46. Plasmalogen deficiency in cerebral adrenoleukodystrophy and its modulation by lovastatin. J Neurochem. 2008 Aug; 106(4):1766-79.
    View in: PubMed
    Score: 0.023
  47. Statin inhibits kainic acid-induced seizure and associated inflammation and hippocampal cell death. Neurosci Lett. 2008 Aug 08; 440(3):260-4.
    View in: PubMed
    Score: 0.023
  48. Lovastatin inhibits amyloid precursor protein (APP) beta-cleavage through reduction of APP distribution in Lubrol WX extractable low density lipid rafts. J Neurochem. 2008 May; 105(4):1536-49.
    View in: PubMed
    Score: 0.022
  49. Inhibition of rho family functions by lovastatin promotes myelin repair in ameliorating experimental autoimmune encephalomyelitis. Mol Pharmacol. 2008 May; 73(5):1381-93.
    View in: PubMed
    Score: 0.022
  50. Lactosylceramide: a lipid second messenger in neuroinflammatory disease. J Neurochem. 2007 Nov; 103 Suppl 1:180-91.
    View in: PubMed
    Score: 0.022
  51. S-nitrosoglutathione prevents interphotoreceptor retinoid-binding protein (IRBP(161-180))-induced experimental autoimmune uveitis. J Ocul Pharmacol Ther. 2007 Jun; 23(3):221-31.
    View in: PubMed
    Score: 0.021
  52. T-bet is essential for the progression of experimental autoimmune encephalomyelitis. Immunology. 2006 Jul; 118(3):384-91.
    View in: PubMed
    Score: 0.020
  53. Pharmacological strategies for the regulation of inducible nitric oxide synthase: neurodegenerative versus neuroprotective mechanisms. Neurochem Int. 2006 Jul; 49(2):170-82.
    View in: PubMed
    Score: 0.020
  54. Molecular organization of peroxisomal enzymes: protein-protein interactions in the membrane and in the matrix. Arch Biochem Biophys. 2006 Jul 15; 451(2):128-40.
    View in: PubMed
    Score: 0.020
  55. Cerebrovascular protection by various nitric oxide donors in rats after experimental stroke. Nitric Oxide. 2006 Sep; 15(2):114-24.
    View in: PubMed
    Score: 0.019
  56. Sphingolipid signaling and redox regulation. Free Radic Biol Med. 2006 Jun 01; 40(11):1875-88.
    View in: PubMed
    Score: 0.019
  57. Rho/ROCK pathway as a target of tumor therapy. J Neurosci Res. 2006 Feb 01; 83(2):243-55.
    View in: PubMed
    Score: 0.019
  58. 5-Aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside inhibits cancer cell proliferation in vitro and in vivo via AMP-activated protein kinase. J Biol Chem. 2005 Nov 25; 280(47):39582-93.
    View in: PubMed
    Score: 0.019
  59. HMG-CoA reductase inhibitor augments survival and differentiation of oligodendrocyte progenitors in animal model of multiple sclerosis. FASEB J. 2005 Sep; 19(11):1407-21.
    View in: PubMed
    Score: 0.019
  60. The use of N-acetylcysteine for the prevention of hypertension in the reduced uterine perfusion pressure model for preeclampsia in Sprague-Dawley rats. Am J Obstet Gynecol. 2005 Sep; 193(3 Pt 2):952-6.
    View in: PubMed
    Score: 0.019
  61. Involvement of phospholipase A2 and lipoxygenase in lipopolysaccharide-induced inducible nitric oxide synthase expression in glial cells. Glia. 2005 Jul; 51(1):13-21.
    View in: PubMed
    Score: 0.018
  62. 5-aminoimidazole-4-carboxamide ribonucleoside: a novel immunomodulator with therapeutic efficacy in experimental autoimmune encephalomyelitis. J Immunol. 2005 Jul 01; 175(1):566-74.
    View in: PubMed
    Score: 0.018
  63. Attenuation of acute inflammatory response by atorvastatin after spinal cord injury in rats. J Neurosci Res. 2005 Feb 01; 79(3):340-50.
    View in: PubMed
    Score: 0.018
  64. S-Nitrosoglutathione reduces inflammation and protects brain against focal cerebral ischemia in a rat model of experimental stroke. J Cereb Blood Flow Metab. 2005 Feb; 25(2):177-92.
    View in: PubMed
    Score: 0.018
  65. A novel role of lactosylceramide in the regulation of tumor necrosis factor alpha-mediated proliferation of rat primary astrocytes. Implications for astrogliosis following neurotrauma. J Biol Chem. 2005 Apr 08; 280(14):13742-51.
    View in: PubMed
    Score: 0.018
  66. Adenosine kinase inhibitor attenuates the expression of inducible nitric oxide synthase in glial cells. Neuropharmacology. 2005 Jan; 48(1):151-60.
    View in: PubMed
    Score: 0.018
  67. Dual role of cAMP in iNOS expression in glial cells and macrophages is mediated by differential regulation of p38-MAPK/ATF-2 activation and iNOS stability. Free Radic Biol Med. 2004 Dec 01; 37(11):1834-44.
    View in: PubMed
    Score: 0.018
  68. The 15-deoxy-delta12,14-prostaglandin J2 inhibits the inflammatory response in primary rat astrocytes via down-regulating multiple steps in phosphatidylinositol 3-kinase-Akt-NF-kappaB-p300 pathway independent of peroxisome proliferator-activated receptor gamma. J Immunol. 2004 Oct 15; 173(8):5196-208.
    View in: PubMed
    Score: 0.017
  69. Impaired peroxisomal function in the central nervous system with inflammatory disease of experimental autoimmune encephalomyelitis animals and protection by lovastatin treatment. Brain Res. 2004 Oct 01; 1022(1-2):1-11.
    View in: PubMed
    Score: 0.017
  70. Inflammatory mediator and beta-amyloid (25-35)-induced ceramide generation and iNOS expression are inhibited by vitamin E. Free Radic Biol Med. 2004 Aug 01; 37(3):325-38.
    View in: PubMed
    Score: 0.017
  71. Regulation of gene expression associated with acute experimental autoimmune encephalomyelitis by Lovastatin. J Neurosci Res. 2004 Jul 01; 77(1):63-81.
    View in: PubMed
    Score: 0.017
  72. A novel role of lactosylceramide in the regulation of lipopolysaccharide/interferon-gamma-mediated inducible nitric oxide synthase gene expression: implications for neuroinflammatory diseases. J Neurosci. 2004 Jun 30; 24(26):5942-54.
    View in: PubMed
    Score: 0.017
  73. The role of neutral sphingomyelinase produced ceramide in lipopolysaccharide-mediated expression of inducible nitric oxide synthase. J Neurochem. 2004 Feb; 88(3):583-93.
    View in: PubMed
    Score: 0.017
  74. Potential targets of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor for multiple sclerosis therapy. J Immunol. 2004 Jan 15; 172(2):1273-86.
    View in: PubMed
    Score: 0.017
  75. 5-aminoimidazole-4-carboxamide-1-beta-4-ribofuranoside inhibits proinflammatory response in glial cells: a possible role of AMP-activated protein kinase. J Neurosci. 2004 Jan 14; 24(2):479-87.
    View in: PubMed
    Score: 0.017
  76. Rho A negatively regulates cytokine-mediated inducible nitric oxide synthase expression in brain-derived transformed cell lines: negative regulation of IKKalpha. Free Radic Biol Med. 2003 Nov 01; 35(9):1037-50.
    View in: PubMed
    Score: 0.016
  77. Peroxisomal fatty acid oxidation and cellular redox. Methods Enzymol. 2002; 352:361-72.
    View in: PubMed
    Score: 0.014
  78. Identification of the pathway of alpha-oxidation of cerebronic acid in peroxisomes. Lipids. 2000 Oct; 35(10):1127-33.
    View in: PubMed
    Score: 0.013
  79. Asymmetric dimethylarginine exacerbates cognitive dysfunction associated with cerebrovascular pathology. FASEB J. 2020 05; 34(5):6808-6823.
    View in: PubMed
    Score: 0.013
  80. Investigation of S-Nitrosoglutathione in stroke: A systematic review and meta-analysis of literature in pre-clinical and clinical research. Exp Neurol. 2020 06; 328:113262.
    View in: PubMed
    Score: 0.013
  81. Intraperoxisomal localization of very-long-chain fatty acyl-CoA synthetase: implication in X-adrenoleukodystrophy. Exp Cell Res. 2000 Feb 01; 254(2):309-20.
    View in: PubMed
    Score: 0.013
  82. Isolation and biochemical characterization of peroxisomes from cultured rat glial cells. Neurochem Res. 2000 Feb; 25(2):197-203.
    View in: PubMed
    Score: 0.013
  83. Endotoxin-induced alterations of lipid and fatty acid compositions in rat liver peroxisomes. J Endotoxin Res. 2000; 6(1):41-50.
    View in: PubMed
    Score: 0.013
  84. Induction of the manganese superoxide dismutase gene by sphingomyelinase and ceramide. J Neurochem. 1999 Aug; 73(2):513-20.
    View in: PubMed
    Score: 0.012
  85. Amelioration of experimental allergic encephalomyelitis in Lewis rats by lovastatin. Neurosci Lett. 1999 Jul 09; 269(2):71-4.
    View in: PubMed
    Score: 0.012
  86. Inhibition of phosphatidylinositol 3-kinase induces nitric-oxide synthase in lipopolysaccharide- or cytokine-stimulated C6 glial cells. J Biol Chem. 1999 Mar 12; 274(11):7528-36.
    View in: PubMed
    Score: 0.012
  87. Localization of nervonic acid beta-oxidation in human and rodent peroxisomes: impaired oxidation in Zellweger syndrome and X-linked adrenoleukodystrophy. J Lipid Res. 1998 Nov; 39(11):2161-71.
    View in: PubMed
    Score: 0.012
  88. Amelioration of spinal cord injury in rats by blocking peroxynitrite/calpain activity. BMC Neurosci. 2018 08 13; 19(1):50.
    View in: PubMed
    Score: 0.011
  89. Combined treatment with GSNO and CAPE accelerates functional recovery via additive antioxidant activities in a mouse model of TBI. J Neurosci Res. 2018 12; 96(12):1900-1913.
    View in: PubMed
    Score: 0.011
  90. Cytokine-induced accumulation of very long-chain fatty acids in rat C6 glial cells: implication for X-adrenoleukodystrophy. J Neurochem. 1998 Jul; 71(1):78-87.
    View in: PubMed
    Score: 0.011
  91. Protective effect of S-nitrosoglutathione administration against hyperglycemia induced disruption of blood brain barrier is mediated by modulation of tight junction proteins and cell adhesion molecules. Neurochem Int. 2018 09; 118:205-216.
    View in: PubMed
    Score: 0.011
  92. Pathology of nNOS-Expressing GABAergic Neurons in Mouse Model of Alzheimer's Disease. Neuroscience. 2018 08 01; 384:41-53.
    View in: PubMed
    Score: 0.011
  93. Inhibitors of protein phosphatase 1 and 2A differentially regulate the expression of inducible nitric-oxide synthase in rat astrocytes and macrophages. J Biol Chem. 1998 May 15; 273(20):12219-26.
    View in: PubMed
    Score: 0.011
  94. Therapy for X-adrenoleukodystrophy: normalization of very long chain fatty acids and inhibition of induction of cytokines by cAMP. J Lipid Res. 1998 May; 39(5):1091-100.
    View in: PubMed
    Score: 0.011
  95. Abnormality in catalase import into peroxisomes leads to severe neurological disorder. Proc Natl Acad Sci U S A. 1998 Mar 17; 95(6):2961-6.
    View in: PubMed
    Score: 0.011
  96. Sphingomyelinase and ceramide stimulate the expression of inducible nitric-oxide synthase in rat primary astrocytes. J Biol Chem. 1998 Jan 30; 273(5):2591-600.
    View in: PubMed
    Score: 0.011
  97. N-acetyl cysteine inhibits induction of no production by endotoxin or cytokine stimulated rat peritoneal macrophages, C6 glial cells and astrocytes. Free Radic Biol Med. 1998 Jan 01; 24(1):39-48.
    View in: PubMed
    Score: 0.011
  98. Lovastatin and phenylacetate inhibit the induction of nitric oxide synthase and cytokines in rat primary astrocytes, microglia, and macrophages. J Clin Invest. 1997 Dec 01; 100(11):2671-9.
    View in: PubMed
    Score: 0.011
  99. Studies on hepatic injury and antioxidant enzyme activities in rat subcellular organelles following in vivo ischemia and reperfusion. Mol Cell Biochem. 1997 Nov; 176(1-2):337-47.
    View in: PubMed
    Score: 0.011
  100. Vitamin D improves functional outcomes in neonatal hypoxic ischemic male rats treated with N-acetylcysteine and hypothermia. Neuropharmacology. 2017 Sep 01; 123:186-200.
    View in: PubMed
    Score: 0.011
  101. Modulation of endogenous antioxidant enzymes by nitric oxide in rat C6 glial cells. J Neurochem. 1997 May; 68(5):1896-903.
    View in: PubMed
    Score: 0.010
  102. Increasing cAMP attenuates induction of inducible nitric-oxide synthase in rat primary astrocytes. J Biol Chem. 1997 Mar 21; 272(12):7786-91.
    View in: PubMed
    Score: 0.010
  103. Regulation of STAT3 and NF-?B activations by S-nitrosylation in multiple myeloma. Free Radic Biol Med. 2017 05; 106:245-253.
    View in: PubMed
    Score: 0.010
  104. Biochemistry of peroxisomes in health and disease. Mol Cell Biochem. 1997 Feb; 167(1-2):1-29.
    View in: PubMed
    Score: 0.010
  105. Mammalian peroxisomes: metabolism of oxygen and reactive oxygen species. Ann N Y Acad Sci. 1996 Dec 27; 804:612-27.
    View in: PubMed
    Score: 0.010
  106. GSNO promotes functional recovery in experimental TBI by stabilizing HIF-1a. Behav Brain Res. 2018 03 15; 340:63-70.
    View in: PubMed
    Score: 0.010
  107. Topology of ATP-binding domain of adrenoleukodystrophy gene product in peroxisomes. Arch Biochem Biophys. 1996 Oct 15; 334(2):369-79.
    View in: PubMed
    Score: 0.010
  108. S-Nitrosoglutathione ameliorates acute renal dysfunction in a rat model of lipopolysaccharide-induced sepsis. J Pharm Pharmacol. 2016 Oct; 68(10):1310-9.
    View in: PubMed
    Score: 0.010
  109. Sex-specific effects of N-acetylcysteine in neonatal rats treated with hypothermia after severe hypoxia-ischemia. Neurosci Res. 2016 Jul; 108:24-33.
    View in: PubMed
    Score: 0.010
  110. Epoxide hydrolase in human and rat peroxisomes: implication for disorders of peroxisomal biogenesis. J Lipid Res. 1996 Jan; 37(1):159-67.
    View in: PubMed
    Score: 0.010
  111. Tissue differences in antioxidant enzyme gene expression in response to endotoxin. Free Radic Biol Med. 1996; 21(4):533-40.
    View in: PubMed
    Score: 0.010
  112. Targeting the nNOS/peroxynitrite/calpain system to confer neuroprotection and aid functional recovery in a mouse model of TBI. Brain Res. 2016 Jan 01; 1630:159-70.
    View in: PubMed
    Score: 0.009
  113. S-nitrosoglutathione reduces tau hyper-phosphorylation and provides neuroprotection in rat model of chronic cerebral hypoperfusion. Brain Res. 2015 Oct 22; 1624:359-369.
    View in: PubMed
    Score: 0.009
  114. Promoting endothelial function by S-nitrosoglutathione through the HIF-1a/VEGF pathway stimulates neurorepair and functional recovery following experimental stroke in rats. Drug Des Devel Ther. 2015; 9:2233-47.
    View in: PubMed
    Score: 0.009
  115. Role of S-nitrosoglutathione mediated mechanisms in tau hyper-phosphorylation. Biochem Biophys Res Commun. 2015 Feb 27; 458(1):214-9.
    View in: PubMed
    Score: 0.009
  116. Phytanic acid alpha-oxidation in rat liver mitochondria. Biochim Biophys Acta. 1994 Dec 15; 1201(3):491-7.
    View in: PubMed
    Score: 0.009
  117. S-nitrosoglutathione prevents blood-brain barrier disruption associated with increased matrix metalloproteinase-9 activity in experimental diabetes. J Neurochem. 2015 Mar; 132(5):595-608.
    View in: PubMed
    Score: 0.009
  118. Effect of vitamin D3 intake on the onset of disease in a murine model of human Krabbe disease. J Neurosci Res. 2015 Jan; 93(1):28-42.
    View in: PubMed
    Score: 0.009
  119. Impairment of peroxisomal beta-oxidation system by endotoxin treatment. Mol Cell Biochem. 1994 Jun 29; 135(2):187-93.
    View in: PubMed
    Score: 0.009
  120. CuZn superoxide dismutase: intraorganellar distribution in peroxisomes. Ann N Y Acad Sci. 1994 Jun 17; 723:406-8.
    View in: PubMed
    Score: 0.009
  121. Morphological analysis of mitochondrial integrity in prolonged cold renal ischemia utilizing Euro-Collins versus University of Wisconsin preservation solution in a whole organ model. Transplant Proc. 1994 Feb; 26(1):122-5.
    View in: PubMed
    Score: 0.008
  122. Alterations of peroxisomal function in ischemia-reperfusion injury of rat kidney. Biochim Biophys Acta. 1993 Oct 20; 1182(3):291-8.
    View in: PubMed
    Score: 0.008
  123. Purification of peroxisomes and subcellular distribution of enzyme activities for activation and oxidation of very-long-chain fatty acids in rat brain. Biochim Biophys Acta. 1993 Sep 29; 1170(1):44-52.
    View in: PubMed
    Score: 0.008
  124. Cerulenin blockade of fatty acid synthase reverses hepatic steatosis in ob/ob mice. PLoS One. 2013; 8(9):e75980.
    View in: PubMed
    Score: 0.008
  125. Expression of antioxidant enzymes in rat kidney during ischemia-reperfusion injury. Mol Cell Biochem. 1993 Aug 25; 125(2):97-104.
    View in: PubMed
    Score: 0.008
  126. Phytanic acid alpha-oxidation. Differential subcellular localization in rat and human tissues and its inhibition by nycodenz. J Biol Chem. 1993 May 15; 268(14):9972-9.
    View in: PubMed
    Score: 0.008
  127. Identification of phytanoyl-CoA ligase as a distinct acyl-CoA ligase in peroxisomes from cultured human skin fibroblasts. FEBS Lett. 1993 May 10; 322(2):101-4.
    View in: PubMed
    Score: 0.008
  128. Role of endogenous psychosine accumulation in oligodendrocyte differentiation and survival: implication for Krabbe disease. Brain Res. 2013 May 01; 1508:44-52.
    View in: PubMed
    Score: 0.008
  129. Thioridazine induces lipid peroxidation in myelin of rat brain. Neuropharmacology. 1993 Feb; 32(2):157-67.
    View in: PubMed
    Score: 0.008
  130. Protective role of S-nitrosoglutathione (GSNO) against cognitive impairment in rat model of chronic cerebral hypoperfusion. J Alzheimers Dis. 2013; 34(3):621-35.
    View in: PubMed
    Score: 0.008
  131. Transport of fatty acids into human and rat peroxisomes. Differential transport of palmitic and lignoceric acids and its implication to X-adrenoleukodystrophy. J Biol Chem. 1992 Jul 05; 267(19):13306-13.
    View in: PubMed
    Score: 0.007
  132. Berry anthocyanidins synergistically suppress growth and invasive potential of human non-small-cell lung cancer cells. Cancer Lett. 2012 Dec 01; 325(1):54-62.
    View in: PubMed
    Score: 0.007
  133. Ischemia-reperfusion injury: biochemical alterations in peroxisomes of rat kidney. Arch Biochem Biophys. 1992 May 15; 295(1):90-100.
    View in: PubMed
    Score: 0.007
  134. Peroxisomal enzyme activities in brain and liver of pups of lactating mothers treated with ciprofibrate. Neurosci Lett. 1992 Apr 27; 138(2):283-6.
    View in: PubMed
    Score: 0.007
  135. Demonstration of Cu-Zn superoxide dismutase in rat liver peroxisomes. Biochemical and immunochemical evidence. J Biol Chem. 1992 Apr 05; 267(10):6870-3.
    View in: PubMed
    Score: 0.007
  136. Peroxisomal activation, transport and oxidation of fatty acids: implications to peroxisomal disorders. Prog Clin Biol Res. 1992; 375:211-22.
    View in: PubMed
    Score: 0.007
  137. Stimulation of functional recovery via the mechanisms of neurorepair by S-nitrosoglutathione and motor exercise in a rat model of transient cerebral ischemia and reperfusion. Restor Neurol Neurosci. 2012; 30(5):383-96.
    View in: PubMed
    Score: 0.007
  138. Progressive endoplasmic reticulum stress contributes to hepatocarcinogenesis in fatty acyl-CoA oxidase 1-deficient mice. Am J Pathol. 2011 Aug; 179(2):703-13.
    View in: PubMed
    Score: 0.007
  139. Preclinical use of longitudinal MRI for screening the efficacy of S-nitrosoglutathione in treating spinal cord injury. J Magn Reson Imaging. 2011 Jun; 33(6):1301-11.
    View in: PubMed
    Score: 0.007
  140. Postnatal development and isolation of peroxisomes from brain. J Neurochem. 1991 Apr; 56(4):1343-53.
    View in: PubMed
    Score: 0.007
  141. Effect of ciprofibrate on the activation and oxidation of very long chain fatty acids. Mol Cell Biochem. 1991 Feb 02; 100(2):159-67.
    View in: PubMed
    Score: 0.007
  142. Increased Plp1 gene expression leads to massive microglial cell activation and inflammation throughout the brain. ASN Neuro. 2010 Sep 27; 2(4):e00043.
    View in: PubMed
    Score: 0.007
  143. Factors that affect postnatal bone growth retardation in the twitcher murine model of Krabbe disease. Biochim Biophys Acta. 2010 Jul-Aug; 1802(7-8):601-8.
    View in: PubMed
    Score: 0.006
  144. Topographical localization of peroxisomal acyl-CoA ligases: differential localization of palmitoyl-CoA and lignoceroyl-CoA ligases. Biochemistry. 1990 Apr 24; 29(16):3981-6.
    View in: PubMed
    Score: 0.006
  145. Reversal of mouse Acyl-CoA oxidase 1 (ACOX1) null phenotype by human ACOX1b isoform [corrected]. Lab Invest. 2010 May; 90(5):696-708.
    View in: PubMed
    Score: 0.006
  146. Effect of clofibrate on peroxisomal lignoceroyl-CoA ligase activity. Biochem Med Metab Biol. 1990 Feb; 43(1):22-9.
    View in: PubMed
    Score: 0.006
  147. Lipid peroxidation and oxidation of lignoceric acid in kidneys from thioridazine treated rats. J Exp Pathol. 1990; 5(4):177-86.
    View in: PubMed
    Score: 0.006
  148. Mitochondrial membrane fluidity changes in renal ischemia. J Exp Pathol. 1990; 5(1):1-6.
    View in: PubMed
    Score: 0.006
  149. Reduction of lipoxidative load by secretory phospholipase A2 inhibition protects against neurovascular injury following experimental stroke in rat. J Neuroinflammation. 2009 Aug 13; 6:21.
    View in: PubMed
    Score: 0.006
  150. Metformin attenuated the autoimmune disease of the central nervous system in animal models of multiple sclerosis. J Immunol. 2009 Jun 15; 182(12):8005-14.
    View in: PubMed
    Score: 0.006
  151. Loss of AMPK exacerbates experimental autoimmune encephalomyelitis disease severity. Biochem Biophys Res Commun. 2009 Aug 14; 386(1):16-20.
    View in: PubMed
    Score: 0.006
  152. Adrenoleukodystrophy: impaired oxidation of fatty acids due to peroxisomal lignoceroyl-CoA ligase deficiency. Arch Biochem Biophys. 1989 May 01; 270(2):722-8.
    View in: PubMed
    Score: 0.006
  153. Combination therapy of lovastatin and rolipram provides neuroprotection and promotes neurorepair in inflammatory demyelination model of multiple sclerosis. Glia. 2009 Jan 15; 57(2):182-93.
    View in: PubMed
    Score: 0.006
  154. Effect of fatty acids and their derivatives on mitochondrial structures. J Exp Pathol. 1989; 4(1):9-15.
    View in: PubMed
    Score: 0.006
  155. Acyl-CoA ligases from rat brain microsomes: an immunochemical study. Biochim Biophys Acta. 1988 Dec 16; 963(3):509-14.
    View in: PubMed
    Score: 0.006
  156. Fatty acid metabolism in renal ischemia. Lipids. 1988 Sep; 23(9):882-4.
    View in: PubMed
    Score: 0.006
  157. Combined medication of lovastatin with rolipram suppresses severity of experimental autoimmune encephalomyelitis. Exp Neurol. 2008 Dec; 214(2):168-80.
    View in: PubMed
    Score: 0.006
  158. Psychosine-induced alterations in peroxisomes of twitcher mouse liver. Arch Biochem Biophys. 2008 Sep 15; 477(2):211-8.
    View in: PubMed
    Score: 0.006
  159. Effect of salicylic acid on mitochondrial-peroxisomal fatty acid catabolism. Pediatr Res. 1988 Mar; 23(3):338-41.
    View in: PubMed
    Score: 0.006
  160. The role of AMPK in psychosine mediated effects on oligodendrocytes and astrocytes: implication for Krabbe disease. J Neurochem. 2008 Jun; 105(5):1820-33.
    View in: PubMed
    Score: 0.005
  161. Modulation of peroxisome proliferator-activated receptor-alpha activity by N-acetyl cysteine attenuates inhibition of oligodendrocyte development in lipopolysaccharide stimulated mixed glial cultures. J Neurochem. 2008 May; 105(3):956-70.
    View in: PubMed
    Score: 0.005
  162. Lipopolysaccharide-induced peroxisomal dysfunction exacerbates cerebral white matter injury: attenuation by N-acetyl cysteine. Exp Neurol. 2008 Apr; 210(2):560-76.
    View in: PubMed
    Score: 0.005
  163. Caffeic acid phenethyl ester reduces neurovascular inflammation and protects rat brain following transient focal cerebral ischemia. J Neurochem. 2007 Jul; 102(2):365-77.
    View in: PubMed
    Score: 0.005
  164. Post-trauma Lipitor treatment prevents endothelial dysfunction, facilitates neuroprotection, and promotes locomotor recovery following spinal cord injury. J Neurochem. 2007 Apr; 101(1):182-200.
    View in: PubMed
    Score: 0.005
  165. GSNO attenuates EAE disease by S-nitrosylation-mediated modulation of endothelial-monocyte interactions. Glia. 2007 Jan 01; 55(1):65-77.
    View in: PubMed
    Score: 0.005
  166. Immunomodulatory effect of combination therapy with lovastatin and 5-aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside alleviates neurodegeneration in experimental autoimmune encephalomyelitis. Am J Pathol. 2006 Sep; 169(3):1012-25.
    View in: PubMed
    Score: 0.005
  167. Complement plays an important role in spinal cord injury and represents a therapeutic target for improving recovery following trauma. Am J Pathol. 2006 Sep; 169(3):1039-47.
    View in: PubMed
    Score: 0.005
  168. 5-aminoimidazole-4-carboxamide-1-beta-4-ribofuranoside attenuates experimental autoimmune encephalomyelitis via modulation of endothelial-monocyte interaction. J Neurosci Res. 2006 Aug 15; 84(3):614-25.
    View in: PubMed
    Score: 0.005
  169. Combination of systemic hypothermia and N-acetylcysteine attenuates hypoxic-ischemic brain injury in neonatal rats. Pediatr Res. 2006 May; 59(5):684-9.
    View in: PubMed
    Score: 0.005
  170. Krabbe disease: psychosine-mediated activation of phospholipase A2 in oligodendrocyte cell death. J Lipid Res. 2006 Jul; 47(7):1478-92.
    View in: PubMed
    Score: 0.005
  171. IL-4-induced peroxisome proliferator-activated receptor gamma activation inhibits NF-kappaB trans activation in central nervous system (CNS) glial cells and protects oligodendrocyte progenitors under neuroinflammatory disease conditions: implication for CNS-demyelinating diseases. J Immunol. 2006 Apr 01; 176(7):4385-98.
    View in: PubMed
    Score: 0.005
  172. Dysfunction of peroxisomes in twitcher mice brain: a possible mechanism of psychosine-induced disease. Biochem Biophys Res Commun. 2006 Apr 28; 343(1):229-38.
    View in: PubMed
    Score: 0.005
  173. Inhibition of phosphoinositide 3 kinase-Akt (protein kinase B)-nuclear factor-kappa B pathway by lovastatin limits endothelial-monocyte cell interaction. J Neurochem. 2005 Jul; 94(1):204-14.
    View in: PubMed
    Score: 0.005
  174. Peroxisomal participation in psychosine-mediated toxicity: implications for Krabbe's disease. J Neurosci Res. 2005 Jun 15; 80(6):845-54.
    View in: PubMed
    Score: 0.005
  175. N-acetylcysteine prevents endotoxin-induced degeneration of oligodendrocyte progenitors and hypomyelination in developing rat brain. J Neurosci Res. 2004 Nov 01; 78(3):347-61.
    View in: PubMed
    Score: 0.004
  176. Attenuation of ischemia-reperfusion injury in a canine model of autologous renal transplantation. Transplantation. 2004 Sep 15; 78(5):654-9.
    View in: PubMed
    Score: 0.004
  177. Administration of N-acetylcysteine after focal cerebral ischemia protects brain and reduces inflammation in a rat model of experimental stroke. J Neurosci Res. 2004 May 15; 76(4):519-27.
    View in: PubMed
    Score: 0.004
  178. The involvement of glucose metabolism in the regulation of inducible nitric oxide synthase gene expression in glial cells: possible role of glucose-6-phosphate dehydrogenase and CCAAT/enhancing binding protein. J Neurosci. 2003 Aug 20; 23(20):7470-8.
    View in: PubMed
    Score: 0.004
  179. N-Acetyl cysteine protects against injury in a rat model of focal cerebral ischemia. Brain Res. 2003 May 02; 971(1):1-8.
    View in: PubMed
    Score: 0.004
  180. Attenuation of renal ischemia/reperfusion injury by a triple drug combination therapy. J Nephrol. 2003 Jan-Feb; 16(1):63-74.
    View in: PubMed
    Score: 0.004
  181. Combination therapy of N-acetylcysteine, sodium nitroprusside and phosphoramidon attenuates ischemia-reperfusion injury in rat kidney. Mol Cell Biochem. 2002 Nov; 240(1-2):9-17.
    View in: PubMed
    Score: 0.004
  182. Endotoxin induces structure-function alterations of rat liver peroxisomes: Kupffer cells released factors as possible modulators. Hepatology. 2000 Feb; 31(2):446-55.
    View in: PubMed
    Score: 0.003
  183. Kidney ischemia-reperfusion: modulation of antioxidant defenses. Mol Cell Biochem. 2000 Feb; 205(1-2):1-11.
    View in: PubMed
    Score: 0.003
  184. Cytokine-mediated induction of ceramide production is redox-sensitive. Implications to proinflammatory cytokine-mediated apoptosis in demyelinating diseases. J Biol Chem. 1998 Aug 07; 273(32):20354-62.
    View in: PubMed
    Score: 0.003
  185. Antioxidant enzymes in ciprofibrate-induced oxidative stress. Carcinogenesis. 1994 Sep; 15(9):1923-30.
    View in: PubMed
    Score: 0.002
  186. Peroxisomal participation in the cellular response to the oxidative stress of endotoxin. Mol Cell Biochem. 1993 Sep 08; 126(1):25-35.
    View in: PubMed
    Score: 0.002
  187. Visualization of multiple imidazoline/guanidinium-receptive sites. J Biol Chem. 1993 Jul 25; 268(21):16047-51.
    View in: PubMed
    Score: 0.002
  188. Effect of salicylic acid and calcium on mitochondrial functions. Acta Neurol Scand. 1992 Mar; 85(3):191-6.
    View in: PubMed
    Score: 0.002
  189. X-ray diffraction analysis of myelin lipid/proteolipid protein multilayers. J Neurosci Res. 1989 Oct; 24(2):192-200.
    View in: PubMed
    Score: 0.002
  190. Effect of ischemia and 24 hour reperfusion on ATP synthesis in the rat kidney. J Exp Pathol. 1989; 4(1):29-36.
    View in: PubMed
    Score: 0.001
  191. Calcium-activated neutral proteinase in rat brain myelin and subcellular fractions. J Neurosci Res. 1988 Jul; 20(3):351-8.
    View in: PubMed
    Score: 0.001
  192. Synthesis and acylation of myelin proteolipid protein in quaking mouse brain. Metab Brain Dis. 1986 Dec; 1(4):241-7.
    View in: PubMed
    Score: 0.001
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.